Kate Clouse

Kate Clouse

Auto-generated profile, based on publicly available information

Kate Clouse

Health Economics and Epidemiology Research Office, University of the Witwatersrand, Johannesburg, South Africa

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2014 in JAIDS Journal of Acquired Immune Deficiency Syndromes
Verified
Journal Article
Closed access
KCKate Clouse
Kate Clouse
SSSheree Schwartz
Sheree Schwartz
ARAnnelies Van Rie
Annelies Van Rie
JBJean Mbbch Bassett
Jean Mbbch Bassett
NYNompumelelo Yende
Nompumelelo Yende
APAudrey Pettifor
Audrey Pettifor
Background: Women initiating antiretroviral therapy during pregnancy have high rates of dropout, particularly after delivery. We aimed to identify challenges to postpartum retention in care under Option B+, which expands antiretroviral therapy access to all HIV-positive pregnant women regardless of CD4 count. Methodology: We performed 2 semi-structured interviews (SSI, n = 50) and 1 focus group discussion (n = 8) with HIV-positive women at Witkoppen Health and Welfare Centre, a primary care facility in Johannesburg, South Africa, that is one of the only clinics offering Option B+ in South Africa. Results: Fifty women completed the SSI before delivery, and 48 (96%) completed the second SSI within 3 months of delivery. Median age was 28 years (interquartile range: 26–34); most women worked (62%) or had worked in the previous year (18%). Postpartum women attending HIV care perceived that barriers to HIV care after delivery among other women included the belief that mothers care more about the baby's health than their own (29.2%, 14/48), women were “ignorant” or “irresponsible” (16.7%, 8/48), negative clinic staff treatment (12.5%, 6/48), and denial or lack of disclosure of HIV status (10.4% each, 5/48). Experienced barriers included lack of money (18.0%, 9/50), work conflict (6.0%, 3/50), and negative staff treatment (6.0%, 3/50). During the focus group discussion, 3 main themes emerged: conflict with work commitment, negative treatment from health-care workers, and lack of disclosure related to stigma. Conclusions: We identified a complex set of interconnected barriers to retaining postpartum women in HIV care under Option B+, including structural, personal, and societal barriers. The importance of postpartum HIV care for the mother's own health must be embraced by health-care workers and public health programs.

1 February 2013 in JAIDS Journal of Acquired Immune Deficiency Syndromes
Verified
Journal Article
Closed access
KCKate Clouse
Kate Clouse
APAudrey E. Pettifor
Audrey E. Pettifor
MMMHAIRI MASKEW
MHAIRI MASKEW
JBJean Mbbch Bassett
Jean Mbbch Bassett
ARAnnelies Van Rie
Annelies Van Rie
MFMatthew P. Dsc Fox
Matthew P. Dsc Fox
Objective: To compare patient retention at 3 stages of pre-antiretroviral (ART) care and 2 stages of post-ART care to identify when greatest attrition occurs. Design: An observational cohort study. Methods: We reviewed files of all adult nonpregnant individuals testing HIV-positive January 1–June 30, 2010, at a primary health clinic in Johannesburg, South Africa (N = 842). We classified retention in pre-ART stage 1 (HIV diagnosis to CD4 results notification in ≤3 months), pre-ART stage 2 (initially ineligible for ART with repeat CD4 test ≤1 year of prior CD4), pre-ART stage 3 (initiating ART ≤3 months after first eligible CD4 result), and at 0–6 and 6–12 months post-ART. Results: Retention among all patients during pre-ART stage 1 was 69.8% [95% confidence interval (CI): 66.7% to 72.9%]. For patients initially ART ineligible (n = 221), 57.4% (95% CI: 49.5% to 65.0%) returned for a repeat CD4 during pre-ART stage 2. Among those who were ART eligible (n = 589), 73.5% (95% CI: 69.0% to 77.6%) were retained during pre-ART stage 3. Retention increased with time on ART, from 80.2% (95% CI: 75.3% to 84.5%) at 6 months to 95.3% (95% CI: 91.7% to 97.6%) between 6 and 12 months. Cumulative retention from diagnosis to 12 months on ART was 36.9% (95% CI: 33.0% to 41.1%) for those ART eligible and 43.0% (95% CI: 36.4% to 49.8%) from diagnosis to repeat CD4 testing within one year among those ART ineligible. Conclusions: Patient attrition in the first year after HIV diagnosis was greatest before ART initiation: more than 25% at each of 3 pre-ART stages. As countries expand HIV testing and ART programs, success will depend on linkage to care, especially before ART eligibility and initiation.

3 February 2013 in Tropical Medicine & International Health
Verified
Journal Article
Open access
PDF file
KCKate Clouse
Kate Clouse
APAudrey Pettifor
Audrey Pettifor
KSKate Shearer
Kate Shearer
MMMHAIRI MASKEW
MHAIRI MASKEW
JBJean Bassett
Jean Bassett
MFMatthew P. Fox
Matthew P. Fox
Objective: HIV‐positive pregnant women are at heightened risk of becoming lost to follow‐up (LTFU) from HIV care. We examined LTFU before and after delivery among pregnant women newly diagnosed with HIV.Methods: Observational cohort study of all pregnant women ≥18 years (N = 300) testing HIV positive for the first time at their first ANC visit between January and June 2010, at a primary healthcare clinic in Johannesburg, South Africa. Women (n = 27) whose delivery date could not be determined were excluded.Results: Median (IQR) gestation at HIV testing was 26 weeks (21–30). Ninety‐eight per cent received AZT prophylaxis, usually started at the first ANC visit. Of 139 (51.3%) patients who were ART eligible, 66.9% (95% CI 58.8–74.3%) initiated ART prior to delivery; median (IQR) ART duration pre‐delivery was 9.5 weeks (5.1–14.2). Among ART‐eligible patients, 40.5% (32.3–49.0%) were cumulatively retained through 6 months on ART. Of those ART‐ineligible patients at HIV testing, only 22.6% (95% CI 15.9–30.6%) completed CD4 staging and returned for a repeat CD4 test after delivery. LTFU (≥1 month late for last scheduled visit) before delivery was 20.5% (95% CI 16.0–25.6%) and, among those still in care, 47.9% (95% CI 41.2–54.6%) within 6 months after delivery. Overall, 57.5% (95% CI 51.6–63.3%) were lost between HIV testing and 6 months post‐delivery.Conclusions: Our findings highlight the challenge of continuity of care among HIV‐positive pregnant women attending antenatal services, particularly those ineligible for ART.

6 June 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CHColleen F. Hanrahan
Colleen F. Hanrahan
KSKaterina Selibas
Katerina Selibas
CDChristopher B. Deery
Christopher B. Deery
HDHeather Dansey
Heather Dansey
KCKate Clouse
Kate Clouse
ARAnnelies Van Rie
Annelies Van Rie
Introduction In December 2010, the World Health Organization recommended a single Xpert MTB/RIF assay as the initial diagnostic in people suspected of HIV-associated or drug resistant tuberculosis. Few data are available on the impact of this recommendation on patient outcomes. We describe the diagnostic follow-up, clinical characteristics and outcomes of a cohort of tuberculosis suspects screened using a single point-of-care Xpert. Methods Consecutive tuberculosis suspects at a primary care clinic in Johannesburg, South Africa were assessed for tuberculosis using point-of-care Xpert. Sputum smear microscopy and liquid culture were performed as reference standards. Xpert-negatives were evaluated clinically, and further assessed at the discretion of clinicians. Participants were followed for six months. Results From July-September 2011, 641 tuberculosis suspects were enrolled, of whom 69% were HIV-infected. Eight percent were positive by a single Xpert. Among 116 individuals diagnosed with TB, 66 (57%) were Xpert negative, of which 44 (67%) were empirical or radiological diagnoses and 22 (33%) were Xpert negative/culture-positive. The median time to tuberculosis treatment was 0 days (IQR: 0–0) for Xpert positives, 14 days (IQR: 5–35) for those diagnosed empirically, 14 days (IQR: 7–29) for radiological diagnoses, and 144 days (IQR: 28–180) for culture positives. Xpert negative tuberculosis cases were clinically similar to Xpert positives, including HIV status and CD4 count, and had similar treatment outcomes including mortality and time to antiretroviral treatment initiation. Conclusions In a high HIV-burden setting, a single Xpert identified less than half of those started on tuberculosis treatment, highlighting the complexity of TB diagnosis even in the Xpert era. Xpert at point-of-care resulted in same day treatment initiation in Xpert-positives, but had no impact on tuberculosis treatment outcomes or mortality.

1 April 2017 in JAIDS Journal of Acquired Immune Deficiency Syndromes
Verified
Journal Article
Closed access
KCKate Clouse
Kate Clouse
Sten H. VermundSten H. Vermund
Sten H. Vermund
MMMHAIRI MASKEW
MHAIRI MASKEW
MLMark N. Lurie
Mark N. Lurie
WMWilliam MacLeod
William MacLeod
MFMatthew P. Dsc Fox
Matthew P. Dsc Fox
Objective: Retention in HIV care, particularly among postpartum women, is a challenge to national antiretroviral therapy programs. Retention estimates may be underestimated because of unreported transfers. We explored mobility and clinic switching among patients considered lost to follow-up (LTFU). Design: Observational cohort study. Methods: Of 788 women initiating antiretroviral therapy during pregnancy at 6 public clinics in Johannesburg, South Africa, 300 (38.1%) were LTFU (no visit ≥3 months). We manually searched for these women in the South African National Health Laboratory Services database to assess continuity of HIV care. We used geographic information system tools to map mobility to new facilities. Results: Over one-third (37.6%) of women showed evidence of continued HIV care after LTFU. Of these, 67.0% continued care in the same province as the origin clinic. Compared with those who traveled outside of the province for care, these same-province “clinic shoppers” stayed out-of-care longer {median 373 days [interquartile range (IQR): 175–790] vs. 175.5 days (IQR: 74–371)} and had a lower CD4+ cell count on re-entry [median 327 cells/μL (IQR: 196–576) vs. 493 cells/μL (IQR: 213–557). When considering all women with additional evidence of care as engaged in care, cohort LTFU dropped from 38.1% to 25.0%. Conclusions: We found evidence of continued care after LTFU and identified local and national clinic mobility among postpartum women. Laboratory records do not show all clinic visits and manual matching may have been under- or overestimated. A national health database linked to a unique identifier is necessary to improve reporting and patient care among highly mobile populations.

19 July 2018 in Journal of the International AIDS Society
Verified
Journal Article
Open access
PDF file
TPTamsin K Phillips
Tamsin K Phillips
KCKate Clouse
Kate Clouse
AZAllison Zerbe
Allison Zerbe
COCatherine Orrell
Catherine Orrell
EAElaine J Abrams
Elaine J Abrams
LMLandon Myer
Landon Myer
Introduction: Linkage to care and mobility postpartum present challenges to long‐term retention after initiating antiretroviral therapy (ART) in pregnancy, but there are few insights from sub‐Saharan Africa. We aimed to describe postpartum linkage to care, mobility, retention and viral suppression after ART initiation in pregnancy.Methods: Using routine electronic data we assessed HIV‐specific health contacts and clinic movements among women initiating ART in an integrated antenatal care (ANC) and ART clinic in Cape Town, South Africa. The local care model includes mandatory transfer to general ART clinics postpartum. We investigated linkage to care after leaving the integrated clinic and mobility to new clinics until 30 months on ART. We used Poisson regression to explore predictors of linkage, retention (accessing care at least once at both 12 [6 to <18] and 24 [18 to <30] months on ART), and viral suppression (HIV viral load [VL] ≤50 and ≤1000 copies/mL after 12 months on ART).Results: Among 617 women, 23% never linked to care; 71% and 65% were retained at 12 and 24 months on ART respectively, with 59% retained in care at both times. Those who linked (n = 485) accessed HIV care at 98 different clinics and 21% attended ≥2 clinics. Women >25 years, married/cohabiting or presenting early for ANC were more likely to link. Younger and unemployed women were more likely to attend ≥2 clinics (adjusted risk ratio [aRR] 1.10 95% confidence interval [CI] 1.02 to 1.18 and aRR 1.06 95% CI 0.99 to 1.12 respectively). Age >25 years (aRR 1.17 95% CI 1.02 to 1.33) and planned pregnancy (aRR 1.20 95% CI 1.09 to 1.33) were associated with being retained. Among 338 retained women with VL available, attending ≥2 clinics reduced the likelihood of viral suppression when defined as ≤50 copies/mL (aRR 0.81 95% CI 0.69 to 0.95). Distance moved was not associated with VL.Conclusions: These data show that a substantial proportion of women do not link to postpartum ART care in this setting and, among those that do, long‐term retention remains a challenge. Women move to a variety of clinics and young women appear particularly vulnerable to attrition. Interventions promoting linkage and continued retention for women initiating ART during pregnancy warrant urgent consideration.